openPR Logo
Press release

U.S. biological research lab confirms SARS-CoV-2 virus levels reduced within minutes by material in a new protective face mask

09-14-2020 08:29 AM CET | Health & Medicine

Press release from: Coppermedics

U.S. biological research lab confirms SARS-CoV-2 virus levels reduced within minutes by material in a new protective face mask

SEOUL, South Korea, Sept. 10, 2020 /PRNewswire/ -- Recently completed tests in the United States at the Colorado State University Biological Safety Level 3 (BSL-3) research laboratory have demonstrated, for the first time, that the surface material of a new face mask can eliminate more than 99.99 percent of the SARS-CoV-2 virus strain within 30 minutes. No other face mask material has demonstrated this capability to date.

Based on the research, 99.57 percent of the virus was neutralized within 10 minutes, when compared to the control material, which lacked the antiviral component. The SARS-CoV-2 virus causes COVID-19.
The material used in the face masks, constructed with the proven and patented antiviral material, is designed to battle the SARS-CoV-2 virus.

Named the "Virus Buster" in the marketplace, several different models of the face mask are being sold throughout the world. The manufacturer is a Korean company named MediFiber.

Reducing the amount of SARS-CoV-2 virus activity on the face mask could make it less likely that wearers will infect themselves by coming into contact with the virus while removing their masks and accidentally touching their mouths, noses or eyes.

The masks are intended to provide two-way protection. They are designed to protect the wearer from virus droplets that might land on the surface of the wearer's mask. The antiviral material, known as "CAZ," is also potentially capable of deactivating viral droplets from being exhaled by anyone infected by COVID-19 illness.

The tests at Colorado State University's BSL-3 laboratory were arranged for the manufacturer by Coppermedics, a sales and marketing consultancy focused on copper's public health potential. The CSU team did not conduct any particle filtration efficiency tests on the material.

The Virus Buster product line is currently being represented in six countries:

In the United States: By Coppermedics, which can be reached online at Coppermedics.com, by email at sales@coppermedics.com or by phone at 1-310-993-9929.

In France: fr@virusbuster.co.kr
In Germany: de@virusbuster.co.kr
In the United Kingdom: uk@virusbuster.co.kr
In Japan: jp@virusbuster.co.kr
In Korea : sales@virusbuster.co.kr or by phone at 82-70-4152-7072

The Virus Buster face masks are intended for frontline workers, employees of large organizations, staff and residents of care-giving institutions and members of the public.

Tests of the copper-containing CAZ material were performed at the BSL-3 laboratory at Colorado State University at Fort Collins, under the direction of Nicole Kruh-Garcia, assistant professor in the Department of Microbiology, Immunology and Pathology. The testing was performed according to protocols specified in ISO 18184:2019, an international standard for determining the antiviral activity of textiles.

The tests demonstrated that 99.57 percent of the actual SARS-CoV-2 virus deposited on the copper ion-bonded material was inactivated in 10 minutes, and that more than 99.999 percent was inactivated within 30 minutes.

"Based on this laboratory testing, MediFiber believes that the Virus Buster face mask offers a new high level of protection against the SARS-CoV-2 virus strain which causes the COVID-19 illness," said Jungku Woo, CEO of MediFiber.

Two models of the Virus Buster mask, which utilize this antiviral CAZ material, are now available to order: the "Folder Mask 3-D" and the "Wrinkle Mask – medical / dental / surgical style."

The Virus Buster mask is comprised of four layers of material: the tested outer antiviral layer which includes copper ion-bonded fiber; a virus protection layer containing a nano membrane filter; a support layer; and an innermost skin care layer.

Further information about pricing, delivery, features and benefits of these face masks and a detailed explanation of the lab tests are available, via the indicated sales representative in each listed country.

MediFiber also manufactures air filters comprised of the same antiviral CAZ material tested, intended to eliminate coronavirus circulating in the air conditioning systems in office buildings, classrooms, medical facilities, factories and other large spaces.

Notice and Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration or comparable health authorities in the European Union or the United Kingdom. These products are not intended to diagnose, treat or cure any disease.

SOURCE: COPPERMEDICS

Related Links https://coppermedics.com/

Mark Zuckerman
Coppermedics
Sebastopol, CA, U.S.A.
310-993-9929
mark.zuckerman@coppermedics.com

Coppermedics serves as a sales representative in the United States for the Korean manufacturer, MediFiber. Coppermedics can be reached at its Website, https://www.coppermedics.com or by phone at: 310-993-9929

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. biological research lab confirms SARS-CoV-2 virus levels reduced within minutes by material in a new protective face mask here

News-ID: 2132954 • Views:

More Releases for Virus

Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects. Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817 The outbreak of Zika virus infection in Latin
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism